Rivaplast 9mg Transdermal Patch
Prescription Required
Product introduction
Rivaplast 9mg Transdermal Patch helps treat mild to moderate dementia in Alzheimer’s disease, a progressive (worsening) illness that gradually affects memory and thinking. It is also used to treat Dementia in Parkinson’s disease. It does not cure these illnesses but may help improve memory, awareness, and other symptoms.
Rivaplast 9mg Transdermal Patch is used to treat symptoms of Alzheimer's disease that include memory loss, confusion and behaviour changes
Rivaplast 9mg Transdermal Patch is used to treat symptoms of Alzheimer's disease that include memory loss, confusion and behaviour changes
Uses of Rivaplast Transdermal Patch
- Alzheimer's disease
Benefits of Rivaplast Transdermal Patch
In Alzheimer's disease
In people with Alzheimer’s disease, certain nerve cells die in the brain. This results in lower levels of a chemical called acetylcholine which helps nerve cells to communicate with each other. This leads to symptoms of dementia such as memory loss, confusion, disorientation, problems with speech and language, and personality changes. Rivaplast 9mg Transdermal Patch increases the amount of acetylcholine and helps brain cells to communicate. It can, therefore, improve some of the symptoms such as memory, awareness, and the ability to carry out daily functions for a time. However, it is not a cure.
You should use the patches exactly as they have been prescribed and only use one at a time. Choose a different place on your body to wear the patch each time you put on a new one. It can take several weeks for your symptoms to improve; so keep applying the patches even if you do not think they are working.
You should use the patches exactly as they have been prescribed and only use one at a time. Choose a different place on your body to wear the patch each time you put on a new one. It can take several weeks for your symptoms to improve; so keep applying the patches even if you do not think they are working.
Side effects of Rivaplast Transdermal Patch
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Rivaplast
- Abdominal pain
- Delirium (acute confusional state)
- Urinary tract infection
- Fainting
- Depression
- Rash
- Fever
- Application site reactions (burning, irritation, itching and redness)
- Nausea
- Vomiting
- Indigestion
- Loss of appetite
How to use Rivaplast Transdermal Patch
Use this medicine in dose and duration as advised by your doctor. Check the label before use. Make sure the skin is clean and dry. Remove the protective liner of the patch. Do not touch the sticky side. With sticky side down, place the patch evenly onto the skin.
How Rivaplast Transdermal Patch works
Memory loss in Alzheimer’s disease occurs due to disturbances in the transmission of signals within the brain. Rivaplast 9mg Transdermal Patch is a cholinesterase inhibitor which is absorbed through the skin into the bloodstream. Once absorbed, it works by increasing the levels of a chemical messenger (acetylcholine) involved in the transmission of nerve signals. This improves memory and thinking.
Safety advice
Alcohol
No interaction found/established
Pregnancy
SAFE IF PRESCRIBED
Rivaplast 9mg Transdermal Patch is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
CONSULT YOUR DOCTOR
Rivaplast 9mg Transdermal Patch is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving
No interaction found/established
Kidney
SAFE IF PRESCRIBED
Rivaplast 9mg Transdermal Patch is safe to use in patients with kidney disease. No dose adjustment of Rivaplast 9mg Transdermal Patch is recommended.
However, inform your doctor if you have an underlying kidney disease as close monitoring is advised while you are taking this medicine.
However, inform your doctor if you have an underlying kidney disease as close monitoring is advised while you are taking this medicine.
Liver
SAFE IF PRESCRIBED
Rivaplast 9mg Transdermal Patch is safe to use in patients with liver disease. No dose adjustment of Rivaplast 9mg Transdermal Patch is recommended.
However, inform your doctor if you have an underlying liver disease as close monitoring is advised while you are taking this medicine.
However, inform your doctor if you have an underlying liver disease as close monitoring is advised while you are taking this medicine.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- You have been prescribed Rivaplast 9mg Transdermal Patch to slow down the progression of Alzheimer's disease.
- It does not cure Alzheimer's disease but may help improve brain function and ability to do daily activities.
- Rivaplast 9mg Transdermal Patch is absorbed through the skin continuously. This produces steady blood levels of the medicine.
- To prevent skin irritation, change the location of the patch every day.
- Do not apply the patches to broken, red or irritated skin.
- It may cause diarrhea, nausea, and vomiting. Drink plenty of fluids to keep yourself hydrated while taking Rivaplast 9mg Transdermal Patch.
- Do not drive or do anything that requires mental focus until you know how Rivaplast 9mg Transdermal Patch affects you.
- Inform your doctor if you notice sensitivity and irritation in and around the area where the patch is placed and if it doesn't go away after the patch is removed.
Fact Box
Chemical Class
Carbamate Derivative
Habit Forming
No
Therapeutic Class
NEURO CNS
Action Class
Cholinesterase inhibitors - Alzheimer's disease
Patient concerns
User feedback
Patients taking Rivaplast 9mg Transdermal Patch
Once A Day
96%
Alternate Day
4%
What are you using Rivaplast Transdermal Patch for?
Dementia in P*
60%
Alzheimer's d*
20%
Others
20%
*Dementia in Parkinson's disease, Alzheimer's disease
How much was the improvement?
Average
40%
Excellent
33%
Poor
27%
What were the side-effects while using Rivaplast 9mg Transdermal Patch?
Weakness
50%
Nausea
25%
No Side Effec*
25%
*No Side Effect
How do you take Rivaplast Transdermal Patch?
With or witho*
100%
*With or without food
Please rate Rivaplast 9mg Transdermal Patch on price
Expensive
100%
FAQs
Can I stop taking Rivaplast 9mg Transdermal Patch?
You should not stop or change the dose of Rivaplast 9mg Transdermal Patch without consulting your doctor. However, if the treatment is interrupted for more than 3 days, do not continue the medicine without consulting your doctor. The doctor will re-initiate the treatment with a low dose which can then be increased gradually as was done previously.
Can Rivaplast 9mg Transdermal Patch cause hallucinations?
Yes, Rivaplast 9mg Transdermal Patch can cause hallucinations. However, hallucinations are reported very rarely with the use of Rivaplast 9mg Transdermal Patch, which means they occur in very few people. It may usually occur shortly after dose modification. If you do not feel well, consult your doctor.
Does Rivaplast 9mg Transdermal Patch cause drowsiness?
Yes, Rivaplast 9mg Transdermal Patch can cause drowsiness or sleepiness, especially at the start of treatment or when the dose is increased. If you feel dizzy or sleepy, do not drive, use machines or perform any tasks that require your attention.
Is it okay to take antacids while using Rivaplast 9mg Transdermal Patch?
Yes, antacids can be taken while using Rivaplast 9mg Transdermal Patch as they do not interfere with the working of Rivaplast 9mg Transdermal Patch. The use of Rivaplast 9mg Transdermal Patch may cause increased acid secretion in the stomach in some patients. Hence, your doctor may prescribe an antacid to relieve this acidity caused due to Rivaplast 9mg Transdermal Patch.
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Stahl SM, editor. Rivastigmine. In: Stahl's Essential Pschopharmacology: Prescriber's Guide. 5th ed. New York, New York: Cambridge University Press; 2014. pp. 603-607.
- Katzung BG. Special Aspects of Geriatric Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1041.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1229.
- Rivastigmine. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.;2008 [revised 23 Apr. 2018]. [Accessed 22 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 22 Mar. 2019] (online) Available from:
Marketer details
Name: Zuventus Healthcare Ltd
Address: Office No. 5119, 5th Floor, 'D' Wing, Oberoi Garden Estates, Chandivili, Andheri (E), Mumbai - 400 072.
Country of origin: India
Lab tests offered by us
Related/Popular tests
147 people viewed this recentlyMRP
₹297
Inclusive of all taxes
3.0 transdermal patches in 1 packet
SOLD OUT
Notify me